VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
MASH Treatment Enters the 2.0 Era: From Daily Pills to Monthly Shots — GSK’s New Drug Has Arrived
MASH Treatment Enters the 2.0 Era: From Daily Pills to Monthly Shots — GSK’s New Drug Has Arrived
Jun 12, 2026 18:40 CST Updated 19:08
Share:
GSK China
Pharmaceutical Manufacturer
GSK
Pharmaceutical R&D Manufacturer